COMPANY
HAMELN PHARMA LTD
HAMELN PHARMA LTD: marketing authorisation holder for Daptomycin, Oxytocin, Vancomycin, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Daptomycin | DAPTOMYCIN 350 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 01502/0120, Authorised Regulator MHRA |
|---|---|
| Daptomycin | DAPTOMYCIN 500 MG POWDER FOR SOLUTION FOR INJECTION/INFUSION, PL 01502/0121, Authorised Regulator MHRA |
| Oxytocin | OXYTOCIN 10 IU/ML CONCENTRATE FOR SOLUTION FOR INFUSION, PL 01502/0097, Authorised Regulator MHRA |
| Vancomycin | VANCOMYCIN 1000 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, PL 01502/0131, Authorised Regulator MHRA |
| Vancomycin | VANCOMYCIN 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, PL 01502/0130, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.